Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

A Hgb Exceeding 120g/L Does Not Increase Risk of Vascular Complications or Disease Progression in Patients with MDS Treated with Erythropoietic Stimulating Agents, a Single-Institution Retrospective Study of the MDS-CAN Registry

Clarissa Skorupski, Lisa Chodirker, Lee Mozessohn, James T England, James Kennedy, Matthew C. Cheung, Signy Chow, Jennifer Teichman, Nicola Goldberg, Samantha A. Hershenfeld, Hubert Tsui, Mohammed Siddiqui, Alexandre Mamedov, Liying Zhang, Rena Buckstein

Blood (2024) 144 (Supplement 1): 6716.

https://doi.org/10.1182/blood-2024-209053

Published: 2024

Journal Articles

Integrating the Sunnybrook Biobank into the Future of Healthcare - Exploring Patient and Healthworker Biobanking Perspectives

Noor Kundu, Dylan Gowlett-Park, August Lin, Sila Usta, Tina Khazaee, Katarina Czibere, Alexandra Misura, Olga Bigun, Betty Wong, Samuel Matsumura, Hubert Tsui, Signy Chow

Blood (2024) 144 (Supplement 1): 2293.

https://doi.org/10.1182/blood-2024-209623

Published: 2024

Journal Articles

The Impact of Clonal Hematopoiesis on Clinical Outcomes and Clonal Dynamics in Older Lymphoma Patients Receiving Chemotherapy

Rena Buckstein, Olivia Lopes, Amy J. M. McNaughton, Matthew C. Cheung, Lee Mozessohn, Lisa Chodirker, Kevin Imrie, Neil Berinstein, Signy Chow, Gillian Kupakuwana-Suk, Anne Parmentier, Prasha Sasitharakumar, Hubert Tsui, Liying Zhang, Michael J. Rauh

Blood (2023) 142 (Supplement 1): 442.

https://doi.org/10.1182/blood-2023-187778

Published: 2023

Journal Articles

Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL

Sila Usta, Alexandra Misura, Kim Roos, Iran Rashedi, Irina Amitai, Yidi Jiang, Kathryn Mangoff, Gail Klein, Nicholas Allen Forward, Douglas A. Stewart, Joy Mangel, George A. Tomlinson, Hubert Tsui, Neil Berinstein

Blood (2023) 142 (Supplement 1): 6124.

https://doi.org/10.1182/blood-2023-189200

Published: 2023

Journal Articles

Aberrant Splicing of MBD1 Reshapes the Epigenome to Drive Convergent Myeloerythroid Defects in MDS

Blood (2023) 142 (Supplement 1): 317.

https://doi.org/10.1182/blood-2023-180889

Published: 2023

Journal Articles

Outcomes of Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) Receiving Intensive Vs. Non-Intensive First Line Treatment

Signy Chow, Alexandra Misura, Olga Bigun, Sila Usta, Renato Sasso, Dylan Gowlett-Park, Katarina Czibere, Rena Buckstein, Lee Mozessohn, Lisa Chodirker, James Kennedy, Hubert Tsui

Blood (2023) 142 (Supplement 1): 5840.

https://doi.org/10.1182/blood-2023-188464

Published: 2023

Journal Articles

Stem Cell-Derived Gene Expression Scores Predict Survival and Leukemic Transformation in Myelofibrosis

Jessie J.F. Medeiros, Andy G.X. Zeng, Michelle Chan-Seng-Yue, Tristan Woo, Jessica L McLeod, Andrea Arruda, Hubert Tsui, Burhan Goraya, Jaime O. Claudio, Jenny M. Ho, James A. Kennedy, Dawn Maze, Hassan Sibai, Mark D. Minden, Jean C.Y. Wang, John E. Dick, Vikas Gupta

Blood (2022) 140 (Supplement 1): 9681–9682.

https://doi.org/10.1182/blood-2022-163722

Published: 2022

Journal Articles

CCUS and Low-Risk MDS Are Inherently Similar, Sharing Clonal and Clinical Features

Christina K Ferrone, Amy JM McNaughton, Iran Rashedi, Rena Buckstein, Hubert Tsui, Michael J Rauh

Blood (2022) 140 (Supplement 1): 6915–6916.

https://doi.org/10.1182/blood-2022-169710

Published: 2022

Journal Articles

Dynamic Stromal Changes in Myelofibrosis Patients Pre/Post JAK Inhibition Is Revealed in Clinically Archived Bone Marrow Biopsies By Smooth Muscle Actin (SMA)-CD34 Dual Immunohistochemistry

Katelyn Wang, Iran Rashedi, James T. England, Rashmi S. Goswami, Larissa Liontos, Raheem Peerani, Anne Tierens, Michael J Rauh, Vikas Gupta, Hubert Tsui

Blood (2021) 138 (Supplement 1): 3286.

https://doi.org/10.1182/blood-2021-151458

Published: 2021

Journal Articles

Clinical Features and Long-Term Outcomes in a Molecularly-Annotated Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms

James T. England, Rouslan Kotchetkov, Hubert Tsui, Jose-Mario Capo-Chichi, Andrea Arruda, Sarah Malik, Verna Cheung, Taylor Nye, Hassan Sibai, Vikas Gupta, Dawn Maze

Blood (2021) 138 (Supplement 1): 3648.

https://doi.org/10.1182/blood-2021-148706

Published: 2021

Journal Articles

Clinical Utility of Hematopathologist-Triaged NGS Testing When Investigating Patients with Suspected MDS

Christina K Ferrone, Amy JM McNaughton, Iran Rashedi, Hubert Tsui, Michael J Rauh

Blood (2021) 138 (Supplement 1): 4675.

https://doi.org/10.1182/blood-2021-153594

Published: 2021

Journal Articles

HSCs Fated to Progress to Blast Phase Can be Detected in Myelofibrosis Patients Several Years Prior to Leukemic Transformation

Jenny M. Ho, MD, Jessie J.F. Medeiros, BSc, Michelle Chan-Seng-Yue, Lauren Hummel, BSc, Andrea Arruda, Amanda Mitchell, PhD, Caroline J McNamara, MBBS, James A Kennedy, MD PhD, Anne Tierens, MD PhD, Dawn Maze, MDFRCPC,MSc, Hubert Tsui, MD PhD, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, John E. Dick, PhD

Blood (2019) 134 (Supplement_1): 1676.

https://doi.org/10.1182/blood-2019-130923

Published: 2019

Journal Articles

AML-Fated Clones Arise in Stem and Progenitor Cells in Myelofibrosis Patients Several Years Prior to AML Diagnosis

Jenny M. Ho, MD, Jessie James Franco Medeiros, BSc, Michelle Chan-Seng-Yue, Lauren Hummel, BSc, Andrea Arruda, Amanda Mitchell, PhD, Caroline J McNamara, MBBS, James Kennedy, MD PhD, Anne Tierens, MD PhD, Hubert Tsui, MD PhD, Mark D. Minden, MD PhD, Vikas Gupta, MD FRCP, FRCPath, John E. Dick, PhD

Blood (2018) 132 (Supplement 1): 4321.

https://doi.org/10.1182/blood-2018-99-118889

Published: 2018

Journal Articles

Niche-Targeted Clinical Grade Immunohistochemistry Reveals Heterogeneous Bone Marrow Neuropathy and Novel Stromal Patterns in Primary Myelofibrosis Patients

Hubert Tsui, MD PhD, Rashmi S. Goswami, BSc, MD PhD FRCPC, Emina Torlakovic, MDPhD, Vikas Gupta, MD PhD

Blood (2017) 130 (Supplement 1): 2915.

https://doi.org/10.1182/blood.V130.Suppl_1.2915.2915

Published: 2017

Journal Articles

Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity

Hubert Tsui, MD PhD, Magar Ghazarian, BSc, Shawn Winer, MD MSC, PhD, Hibret Adissu, DVM, DVSc, PhD, Michael Dosch, MD PhD, Marciano D. Reis, MD FRCPC, Daniel Winer, MD, Armand Keating, MD

Blood (2014) 124 (21): 4123.

https://doi.org/10.1182/blood.V124.21.4123.4123

Published: 2014

Journal Articles

Making “Sense” Of Persistent Polyclonal B Cell Lymphocytosis

Hubert Tsui, MD, PhD, Geoff Paltser, PhD, Hibret Adissu, DVM, DVSc, PhD, Michael Dosch, MD, PhD, Armand Keating, MD

Blood (2013) 122 (21): 3500.

https://doi.org/10.1182/blood.V122.21.3500.3500

Published: 2013

NARROW

A Hgb Exceeding 120g/L Does Not Increase Risk of Vascular Complications or Disease Progression in Patients with MDS Treated with Erythropoietic Stimulating Agents, a Single-Institution Retrospective Study of the MDS-CAN Registry

Integrating the Sunnybrook Biobank into the Future of Healthcare - Exploring Patient and Healthworker Biobanking Perspectives

The Impact of Clonal Hematopoiesis on Clinical Outcomes and Clonal Dynamics in Older Lymphoma Patients Receiving Chemotherapy

Intensity of Survivin Expression Correlates with Clinical and Biological Markers of Aggressive R/R DLBCL

Aberrant Splicing of MBD1 Reshapes the Epigenome to Drive Convergent Myeloerythroid Defects in MDS

Outcomes of Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) Receiving Intensive Vs. Non-Intensive First Line Treatment

Stem Cell-Derived Gene Expression Scores Predict Survival and Leukemic Transformation in Myelofibrosis

CCUS and Low-Risk MDS Are Inherently Similar, Sharing Clonal and Clinical Features

Dynamic Stromal Changes in Myelofibrosis Patients Pre/Post JAK Inhibition Is Revealed in Clinically Archived Bone Marrow Biopsies By Smooth Muscle Actin (SMA)-CD34 Dual Immunohistochemistry

Clinical Features and Long-Term Outcomes in a Molecularly-Annotated Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms

Clinical Utility of Hematopathologist-Triaged NGS Testing When Investigating Patients with Suspected MDS

HSCs Fated to Progress to Blast Phase Can be Detected in Myelofibrosis Patients Several Years Prior to Leukemic Transformation

AML-Fated Clones Arise in Stem and Progenitor Cells in Myelofibrosis Patients Several Years Prior to AML Diagnosis

Niche-Targeted Clinical Grade Immunohistochemistry Reveals Heterogeneous Bone Marrow Neuropathy and Novel Stromal Patterns in Primary Myelofibrosis Patients

Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity

Making “Sense” Of Persistent Polyclonal B Cell Lymphocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only